Fig. 2.
![Fig. 2. Sensitivity to three cysteine proteinase inhibitors (0.1 mmol/L HgCl2, 0.2 mmol/L ZAA-diazomethyl-ketone, and 1 mmol/L IodoAcetic acid [IA]), and to the TF inhibitor anti-TF MoAb (0.1 mg/mL final concentration) of the PCA of S-NB4 (left) and R-NB4-306 cells (right) treated with 10−6 mol/L ATRA (▪) or the vehicle (□) for 96 hours. VB cell extracts were incubated with cysteine proteinase inhibitors or the anti-TF MoAb for 30 minutes or the vehicle (control), before the clotting assay. Statistical analysis compares the inhibitor-treated sample with the untreated (vehicle treated) corresponding control. *P < .05, **P < .01.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/92/1/10.1182_blood.v92.1.143.413k18_143_151/5/blod41318002x.jpeg?Expires=1735523433&Signature=RMDTsuyCuaG8saqU~C7bQWWfkWtLTtWEIUFCd-gRpN1kpdwTmwrh4XKk5uqcwDllV-AvnxoTuW-zd0DErR3f4lQDrW0--CpGB6A3I-i9XAixHLiaZEDPB6elmJzraJ1w2Vk6triEw-UZtEf4No58UsyGlo~e2qTnDB6soeXzOM1Ux~qmnu~QJrI8-Oyu~0Gfh78Fe6fDQ4hZYkd-1zBxybCu437tYQxt0IZ-lGhB3oBcwL0UHYkFemlEaU4Isu9bnrVEsWAdkYJzXZdXXjj0C7s4H4SU5pGTXFPhO6LCsLr9n8S1~jHQaHGmlq3QwIaaf2Ev~rQQAROsnbP9vMa6aQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Sensitivity to three cysteine proteinase inhibitors (0.1 mmol/L HgCl2, 0.2 mmol/L ZAA-diazomethyl-ketone, and 1 mmol/L IodoAcetic acid [IA]), and to the TF inhibitor anti-TF MoAb (0.1 mg/mL final concentration) of the PCA of S-NB4 (left) and R-NB4-306 cells (right) treated with 10−6 mol/L ATRA (▪) or the vehicle (□) for 96 hours. VB cell extracts were incubated with cysteine proteinase inhibitors or the anti-TF MoAb for 30 minutes or the vehicle (control), before the clotting assay. Statistical analysis compares the inhibitor-treated sample with the untreated (vehicle treated) corresponding control. *P < .05, **P < .01.
